RSS Feed


December 2021
« Nov    


Tag Cloud


The Atlantic (November 20)

2021/ 11/ 22 by jd in Global News

“The question facing governments in Europe and elsewhere is which approach—carrot versus stick—will prove the most effective. By singling out the unvaccinated, Austria may succeed in increasing its vaccination rate, but it also runs the risk of driving vaccine skepticism even further.”


WARC (March 4)

2021/ 03/ 06 by jd in Global News

“Ultimately, the cookie was one of the aspects of the internet (and, by extension, digital advertising) that gave it a bad name. But at least they were everyone’s problem/opportunity – what comes next could lead to a vast concentration of power.” One proposal, federated learning of cohorts (FLoC), is facing growing skepticism.


The Atlantic (October Issue)

2018/ 10/ 01 by jd in Global News

“Estrangements are political, not personal…. Given the right conditions, any society can turn against democracy. Indeed, if history is anything to go by, all societies eventually will…. Polarization is normal…. Skepticism about liberal democracy is also normal. And the appeal of authoritarianism is eternal.”


Bloomberg (August 19)

2015/ 08/ 20 by jd in Global News

“Beijing still believes money can buy the trust and soft power it craves, which explains the new $100 billion Asian Infrastructure Investment Bank it has sponsored. But as long as analysts don’t feel the Chinese government’s pronouncements are genuinely reliable, skepticism about the yuan will only grow.”


Institutional Investor (August Issue)

2013/ 08/ 11 by jd in Global News

“Facing an image problem,” many Chinese companies are retreating from U.S. exchanges. “Frustrated by low valuations and investor skepticism, Chinese companies are increasingly considering delisting from U.S. stock exchanges.” Since 2009, 24 Chinese companies have delisted, often going private, from the NYSE and Nasdaq. Much investor skepticism is directed at companies that utilized reverse mergers to attain their listing, thereby avoiding the scrutiny that would accompany a normal IPO, but the skepticism has tainted even Chinese companies with solid financials.